Kidney Cancer  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kidney Cancer
NCT00915993: MRI in Predicting Response to Sunitinib Malate in Patients With Stage IV Kidney Cancer

Recruiting
N/A
40
US
sunitinib malate, mutation analysis, immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study, dynamic contrast-enhanced magnetic resonance imaging
University of Pennsylvania, National Cancer Institute (NCI)
Kidney Cancer
05/11
 
NCT00655252 / 2007-005460-28: Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Checkmark RCC
Jan 2013 - Jan 2013: RCC
Checkmark Data - ESMO 2012
Sep 2012 - Sep 2012: Data - ESMO 2012
Checkmark Data -ESMO 2012
More
No Longer Available
N/A
US, Canada, Europe, RoW
Everolimus
Novartis Pharmaceuticals
Metastatic Renal Cell Cancer
 
 
NCT01473043: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

No Longer Available
N/A
Canada, RoW
Axitinib, AG-013736
Pfizer
Renal Cell Carcinoma
03/14
03/14
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Recruiting
N/A
1000
RoW
Meir Medical Center
Kidney Cancer, Prostate Cancer, Bladder Cancer
08/19
08/25

Download Options